<DOC>
	<DOCNO>NCT00937573</DOCNO>
	<brief_summary>The effectiveness , safety , deliverability second generation drug elute stent ( DES ) , include Xience V , need examine real world patient provide level evidence base comfort accompany use first generation device . Randomized clinical trial provide fair evaluation outcome control confound patient procedural characteristic ; however , randomize clinical trial also exclude high risk patient account upwards 80 % real world patient population Wake Forest University Baptist Medical Center ( WFUBMC ) . Clinical follow-up data include non-fatal MI , cause mortality stent thrombosis , well medication compliance , patient undergoing stent therapy include Xience V real world patient population collect WFUBMC . Existing data several control group use compare outcome Xience V include consecutively treat bare metal stent ( BMS ) cohort 1,200 patient , DES cohort 1,200 patient ( 900 sirolimus-eluting 300 paclitaxel-eluting ) treat April 2004 April 2005 . Patients undergoing stent therapy year prior use Xience V , contemporaneous patient receive non-Xience V stent therapy Xience V use serve additional control . All patient data de-identified use unique blind identification code data collection complete . The null hypothesis study state safety outcome ( stent thrombosis , non-fatal MI , death ) Xience V equivalent historical contemporaneous control ; effectiveness outcome ( target lesion target vessel revascularization ) Xience V superior historical contemporaneous BMS control , equivalent historical contemporaneous DES control ; need crossover another stent type equal observe historical DES control . Outcomes report use contemporary measure clinical outcome analyze use Cox proportional hazard survival analysis methodology . These data provide important information clinical effectiveness safety Xience V routine practice .</brief_summary>
	<brief_title>Xience V Wake Forest University Baptist Medical Center ( WFUBMC )</brief_title>
	<detailed_description />
	<criteria>percutaneous coronary intervention stenting</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>stent</keyword>
	<keyword>mortality</keyword>
	<keyword>revascularization</keyword>
	<keyword>stent thrombosis</keyword>
	<keyword>Drug-Eluting Stents</keyword>
</DOC>